Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BLINATUMOMAB for B precursor type acute leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,791 adverse event reports in the FDA FAERS database where BLINATUMOMAB was used for B precursor type acute leukaemia.

Most Reported Side Effects for BLINATUMOMAB

Side Effect Reports % Deaths Hosp.
Pyrexia 1,064 11.6% 157 464
Acute lymphocytic leukaemia recurrent 977 10.7% 320 156
Cytokine release syndrome 952 10.4% 225 304
Off label use 590 6.4% 99 131
Death 588 6.4% 587 89
Neurotoxicity 530 5.8% 69 148
Drug ineffective 345 3.8% 95 100
Headache 335 3.7% 47 135
Neutropenia 265 2.9% 80 74
Febrile neutropenia 262 2.9% 67 142
Therapy non-responder 255 2.8% 105 14
Tremor 250 2.7% 30 109
Seizure 232 2.5% 43 91
Acute lymphocytic leukaemia 223 2.4% 104 48
Infection 221 2.4% 125 61

Other Indications for BLINATUMOMAB

Acute lymphocytic leukaemia (2,777) Product used for unknown indication (2,344) Acute lymphocytic leukaemia recurrent (783) B-cell type acute leukaemia (622) Minimal residual disease (162) Philadelphia chromosome positive (126) Acute lymphocytic leukaemia refractory (115) Philadelphia chromosome negative (90) Philadelphia positive acute lymphocytic leukaemia (86) Diffuse large b-cell lymphoma (66)

Other Drugs Used for B precursor type acute leukaemia

METHOTREXATE (1,067) VINCRISTINE (977) DEXAMETHASONE (662) CYTARABINE (644) CYCLOPHOSPHAMIDE (598) PEGASPARGASE (531) MERCAPTOPURINE (484) DOXORUBICIN (331) DAUNORUBICIN (274) ASPARAGINASE (214)

Related Pages

BLINATUMOMAB Full Profile All B precursor type acute leukaemia Drugs BLINATUMOMAB Demographics BLINATUMOMAB Timeline